Differential biomarker responses of hemolysis, inflammation, and myocardial injury after pulsed-field pulmonary vein isolation: balloon-in-basket vs. circular catheter systems - Summary - MDSpire

Differential biomarker responses of hemolysis, inflammation, and myocardial injury after pulsed-field pulmonary vein isolation: balloon-in-basket vs. circular catheter systems

  • By

  • Jan-Per Wenzel

  • Raed Abdessadok

  • Charlotte Eitel

  • Sorin Popescu

  • Suzanne de Waha

  • Tanja Zeller

  • Karl-Heinz Kuck

  • Roland Richard Tilz

  • Sascha Hatahet

  • May 29, 2026

  • 0 min

Share

Objective:

To assess changes in biomarkers of hemolysis, inflammation, and biochemical myocardial injury using two PFA systems: balloon-in-basket (BiB) and circular catheter (PS), specifically measuring leukocytes, CRP, LDH, haptoglobin, and others.

Key Findings:
  • Both BiB and PS systems achieved acute PVI with significant increases in leukocytes, CRP, LDH, troponin, and CK without inter-group differences.
  • BiB required fewer applications (16 vs. 32, p < 0.001) and more contrast (45 vs. 30 mL, p < 0.001).
  • Haptoglobin decreased significantly in both groups, more pronounced with PS (Δ −13 vs. −4 mg/dL, p = 0.090).
  • Renal function remained stable overall, with one PS patient developing acute kidney injury.
  • In the BiB group, Δ-Hemoglobin correlated inversely with application number (p = 0.046). In the PS group, Δ-Troponin and Δ-CK correlated positively (p < 0.05).
Interpretation:

Despite comparable overall biomarker responses, the differences in haptoglobin decline and the occurrence of a transient acute kidney injury in the PS group suggest potential variations in systemic responses between the two PFA systems, warranting further investigation.

Limitations:
  • The study was non-randomized and conducted at a single center, which may introduce biases.
  • The sample size was limited to 40 patients.
Conclusion:

The clinical relevance of the findings remains uncertain, highlighting the need for further investigation in larger studies to clarify the implications of these biomarker variations.

Original Source(s)

Related Content